Humana Inc. (NYSE:HUM) Given Consensus Rating of “Hold” by Analysts

Shares of Humana Inc. (NYSE:HUM) have received an average rating of “Hold” from the twenty-two brokerages that are covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a sell rating, nine have assigned a hold rating and eight have assigned a buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $293.2105.

Several analysts have recently issued reports on the stock. Sanford C. Bernstein reissued an “outperform” rating and issued a $344.00 price target on shares of Humana in a research report on Tuesday, January 6th. Barclays reissued an “underperformer” rating on shares of Humana in a report on Monday, January 5th. Robert W. Baird cut their price target on Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a report on Thursday, December 11th. Truist Financial reduced their price target on Humana from $300.00 to $285.00 and set a “hold” rating for the company in a research report on Monday, November 10th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Humana in a report on Thursday, January 22nd.

Humana Stock Up 0.2%

HUM stock opened at $193.91 on Monday. The stock has a fifty day moving average of $251.55 and a 200-day moving average of $263.04. Humana has a fifty-two week low of $186.00 and a fifty-two week high of $315.35. The company has a market capitalization of $23.32 billion, a price-to-earnings ratio of 18.17, a PEG ratio of 1.61 and a beta of 0.44. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Montag A & Associates Inc. raised its position in shares of Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after buying an additional 94 shares in the last quarter. CoreCap Advisors LLC increased its stake in Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 37 shares during the last quarter. Rosenberg Matthew Hamilton raised its holdings in shares of Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares in the last quarter. Elevation Point Wealth Partners LLC bought a new stake in shares of Humana during the 2nd quarter valued at about $32,000. Finally, Mather Group LLC. purchased a new position in shares of Humana during the third quarter worth about $34,000. 92.38% of the stock is owned by institutional investors.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.